Citadel Advisors
WINT

Citadel Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Citadel Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-93
Closed -$1K – 9489
2015
Q2 		$1K Sell
93
-50
-35% -$702 ﹤0.01% 8666
2015
Q1 		$2K Sell
143
-271
-65% -$5.33K ﹤0.01% 8436
2014
Q4 		$7K Sell
414
-143
-26% -$3.14K ﹤0.01% 8222
2014
Q3 		$14K Buy
557
+243
+77% +$5.87K ﹤0.01% 7659
2014
Q2 		$8K Sell
314
-465
-60% -$11.9K ﹤0.01% 7640
2014
Q1 		$23K Buy
779
+58
+8% +$1.95K ﹤0.01% 7236
2013
Q4 		$23K Buy
+721
New +$22.5K ﹤0.01% 6399

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Citadel Advisors's WINT Position: Q1 2016 in Review

Citadel Advisors sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 9,091 shares — an estimated $27K sold.

Citadel Advisors first reported a position in WINT in Q4 2013 and held it in 8 quarters. The position peaked at $50K in Q1 2014. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Citadel Advisors reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Citadel Advisors sold 9,091 Windtree Therapeutics Inc shares in Q1 2016, an estimated $27K.
  • Citadel Advisors first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 8 quarters.
  • Citadel Advisors's Windtree Therapeutics Inc position peaked at $50K in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.